Market Cap
24h Vol
20280
Cryptocurrencies
60.09%
Bitcoin Share
Automated Income Machine Rank 4888
$0.000151
Automated Income Machine Rank 4888
Website Twitter
0 AIM

Automated Income Machine
Automated Income Machine
AIM

Automated Income Machine Price
$0.00

Automated Income Machine 24h Vol
$3,654

Automated Income Machine Market Cap
$0

24h Vol
1,879,080 BTC
1 H
0.6 %
24 H
-13.3 %
7 d
-19.92 %
Today Automated Income Machine price in US dollars is currently 0.0002 USD, and if converted to Bitcoin is 0.07765219 BTC. A total of N/A are currently circulating in the Market. Automated Income Machine price is currently experiencing a change of -13.3 %, and check here all cryptocurrency. Over the past 24 hours 0.000 M US dollars Automated Income Machine have been traded on Crypto Exchanges. Get Automated Income Machine's progress by adding it to your favourites and creating a free portfolio.
Full Name
Automated Income Machine
Symbol
AIM
Algorithm
BTC Price
0.07765219 BTC
BTC Market
0 BTC
BTC 24h Vol
1,879,080 BTC
Total Coins Mined
0 AIM
1h
0.6 %
24h
-13.3 %
7d
-19.92 %
Share Automated Income Machine price with others

Description

Description


Aimedis is a medical care platform. It works as an intermediary between doctors and patients in order to create a medical data marketplace, where users can provide medical data to the doctors, and doctors can diagnose patients. At Aimedis, online medical prescriptions are possible as well as access to A.I. (Artificial Intelligence) tools that are able to examine medical data.

The Aimedis (AIM) token is an Ethereum-based (ERC-20) cryptocurrency. It will serve the users as a medium to exchange value between them and/or to pay for other users medical services when using Aimedis. In addition, to buy or sell medical data, AIM tokens are required.

Full Name Aimedis (AIM)
Start Date N/A
Algorithm N/A
Proof Type N/A
Website https://aim.aimedis.com
Twitter @AimedisGlobal
Facebook N/A
Reddit N/A
Block Number N/A
Block Time N/A
Block Reward N/A
Total Coins Mined N/A
Previous Total Coins Mined N/A
Net Hashes Per Second N/A
ICO Details

ICO Details


Aimedis is a medical care platform. It works as an intermediary between doctors and patients in order to create a medical data marketplace, where users can provide medical data to the doctors, and doctors can diagnose patients. At Aimedis, online medical prescriptions are possible as well as access to A.I. (Artificial Intelligence) tools that are able to examine medical data.

The Aimedis (AIM) token is an Ethereum-based (ERC-20) cryptocurrency. It will serve the users as a medium to exchange value between them and/or to pay for other users medical services when using Aimedis. In addition, to buy or sell medical data, AIM tokens are required.

Team:

  • Dr. Michael J. Kaldasch: CEO, MD & founder. 
  • Dr. Ben El Idrissi: COO, MD & founder. 
  • Sankar Ghanesh: CTO. 
  • Dr. Lazaros Fountoukidis: CMO & MD. 

Aimedis ICO will begin on TBA. The ICO token supply represents 50% of the total token supply, so there is a total of 300,000,000 AIM tokens available, for 0.12 USD each. The ICO funding target is 9,000,000 USD, the funding cap is 36,000,000 USD and is expected to end on TBA or when the funding cap is reached.

Token Reserve Split (50%):

  • 20% Community initiatives, marketing & legal;
  • 20% Team, supporters & advisory board;
  • 5% Legal reserve;
  • 5% Reserve.

Aimedis ICO features a bonus of 20% upon the Pre-Sale.

 

ICO Status Upcoming
Token Supply 600000000
Start Date N/A
End Date N/A
Fund Raised (BTC) N/A
Fund Raised (USD) N/A
Start Price (USD) 0.12
Security Audit Company N/A
ICO Legal Form Corporation
ICO Jurisdiction Netherlands
Legal Advisers N/A
Blog https://medium.com/@aimedisglobal
White Paper https://aim.aimedis.com/pdf/WhitepaperEN10.pdf
Read the Disclaimer : All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured from third party sources. We make no warranties of any kind in relation to our content, including but not limited to accuracy and updatedness. No part of the content that we provide constitutes financial advice, legal advice or any other form of advice meant for your specific reliance for any purpose. Any use or reliance on our content is solely at your own risk and discretion. You should conduct your own research, review, analyse and verify our content before relying on them. Trading is a highly risky activity that can lead to major losses, please therefore consult your financial advisor before making any decision. No content on our Site is meant to be a solicitation or offer.